Cargando…

PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis

BACKGROUND: The Mycobacterium tuberculosis (M.tb) protein kinase B (PknB) which is now proved to be essential for the growth and survival of M.tb, is a transmembrane protein with a potential to be a good drug target. However it is not known if this target remains conserved in otherwise resistant iso...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Anamika, Pal, Sudhir K., Pandey, Divya, Fakir, Najneen A., Rathod, Sunita, Sinha, Dhiraj, SivaKumar, S., Sinha, Pallavi, Periera, Mycal, Balgam, Shilpa, Sekar, Gomathi, UmaDevi, K. R., Anupurba, Shampa, Nema, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562987/
https://www.ncbi.nlm.nih.gov/pubmed/28821299
http://dx.doi.org/10.1186/s12941-017-0234-9
_version_ 1783258049858764800
author Gupta, Anamika
Pal, Sudhir K.
Pandey, Divya
Fakir, Najneen A.
Rathod, Sunita
Sinha, Dhiraj
SivaKumar, S.
Sinha, Pallavi
Periera, Mycal
Balgam, Shilpa
Sekar, Gomathi
UmaDevi, K. R.
Anupurba, Shampa
Nema, Vijay
author_facet Gupta, Anamika
Pal, Sudhir K.
Pandey, Divya
Fakir, Najneen A.
Rathod, Sunita
Sinha, Dhiraj
SivaKumar, S.
Sinha, Pallavi
Periera, Mycal
Balgam, Shilpa
Sekar, Gomathi
UmaDevi, K. R.
Anupurba, Shampa
Nema, Vijay
author_sort Gupta, Anamika
collection PubMed
description BACKGROUND: The Mycobacterium tuberculosis (M.tb) protein kinase B (PknB) which is now proved to be essential for the growth and survival of M.tb, is a transmembrane protein with a potential to be a good drug target. However it is not known if this target remains conserved in otherwise resistant isolates from clinical origin. The present study describes the conservation analysis of sequences covering the inhibitor binding domain of PknB to assess if it remains conserved in susceptible and resistant clinical strains of mycobacteria picked from three different geographical areas of India. METHODS: A total of 116 isolates from North, South and West India were used in the study with a variable profile of their susceptibilities towards streptomycin, isoniazid, rifampicin, ethambutol and ofloxacin. Isolates were also spoligotyped in order to find if the conservation pattern of pknB gene remain consistent or differ with different spoligotypes. The impact of variation as found in the study was analyzed using Molecular dynamics simulations. RESULTS: The sequencing results with 115/116 isolates revealed the conserved nature of pknB sequences irrespective of their susceptibility status and spoligotypes. The only variation found was in one strains wherein pnkB sequence had G to A mutation at 664 position translating into a change of amino acid, Valine to Isoleucine. After analyzing the impact of this sequence variation using Molecular dynamics simulations, it was observed that the variation is causing no significant change in protein structure or the inhibitor binding. CONCLUSIONS: Hence, the study endorses that PknB is an ideal target for drug development and there is no pre-existing or induced resistance with respect to the sequences involved in inhibitor binding. Also if the mutation that we are reporting for the first time is found again in subsequent work, it should be checked with phenotypic profile before drawing the conclusion that it would affect the activity in any way. Bioinformatics analysis in our study says that it has no significant effect on the binding and hence the activity of the protein.
format Online
Article
Text
id pubmed-5562987
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55629872017-08-21 PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis Gupta, Anamika Pal, Sudhir K. Pandey, Divya Fakir, Najneen A. Rathod, Sunita Sinha, Dhiraj SivaKumar, S. Sinha, Pallavi Periera, Mycal Balgam, Shilpa Sekar, Gomathi UmaDevi, K. R. Anupurba, Shampa Nema, Vijay Ann Clin Microbiol Antimicrob Research BACKGROUND: The Mycobacterium tuberculosis (M.tb) protein kinase B (PknB) which is now proved to be essential for the growth and survival of M.tb, is a transmembrane protein with a potential to be a good drug target. However it is not known if this target remains conserved in otherwise resistant isolates from clinical origin. The present study describes the conservation analysis of sequences covering the inhibitor binding domain of PknB to assess if it remains conserved in susceptible and resistant clinical strains of mycobacteria picked from three different geographical areas of India. METHODS: A total of 116 isolates from North, South and West India were used in the study with a variable profile of their susceptibilities towards streptomycin, isoniazid, rifampicin, ethambutol and ofloxacin. Isolates were also spoligotyped in order to find if the conservation pattern of pknB gene remain consistent or differ with different spoligotypes. The impact of variation as found in the study was analyzed using Molecular dynamics simulations. RESULTS: The sequencing results with 115/116 isolates revealed the conserved nature of pknB sequences irrespective of their susceptibility status and spoligotypes. The only variation found was in one strains wherein pnkB sequence had G to A mutation at 664 position translating into a change of amino acid, Valine to Isoleucine. After analyzing the impact of this sequence variation using Molecular dynamics simulations, it was observed that the variation is causing no significant change in protein structure or the inhibitor binding. CONCLUSIONS: Hence, the study endorses that PknB is an ideal target for drug development and there is no pre-existing or induced resistance with respect to the sequences involved in inhibitor binding. Also if the mutation that we are reporting for the first time is found again in subsequent work, it should be checked with phenotypic profile before drawing the conclusion that it would affect the activity in any way. Bioinformatics analysis in our study says that it has no significant effect on the binding and hence the activity of the protein. BioMed Central 2017-08-18 /pmc/articles/PMC5562987/ /pubmed/28821299 http://dx.doi.org/10.1186/s12941-017-0234-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gupta, Anamika
Pal, Sudhir K.
Pandey, Divya
Fakir, Najneen A.
Rathod, Sunita
Sinha, Dhiraj
SivaKumar, S.
Sinha, Pallavi
Periera, Mycal
Balgam, Shilpa
Sekar, Gomathi
UmaDevi, K. R.
Anupurba, Shampa
Nema, Vijay
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis
title PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis
title_full PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis
title_fullStr PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis
title_full_unstemmed PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis
title_short PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis
title_sort pknb remains an essential and a conserved target for drug development in susceptible and mdr strains of m. tuberculosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562987/
https://www.ncbi.nlm.nih.gov/pubmed/28821299
http://dx.doi.org/10.1186/s12941-017-0234-9
work_keys_str_mv AT guptaanamika pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT palsudhirk pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT pandeydivya pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT fakirnajneena pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT rathodsunita pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT sinhadhiraj pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT sivakumars pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT sinhapallavi pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT perieramycal pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT balgamshilpa pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT sekargomathi pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT umadevikr pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT anupurbashampa pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis
AT nemavijay pknbremainsanessentialandaconservedtargetfordrugdevelopmentinsusceptibleandmdrstrainsofmtuberculosis